Home > Insider Trading > Filing (0001209191-19-043922)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406652	C Douglas Bryant	12544 High Bluff Drive, Suite 200 San Diego CA 92130	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-07-29	21,789	$15.19	323,231	No	4	M	Direct
Common Stock	Disposition	2019-07-29	21,789	$57.78	301,442	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options	Disposition	2019-07-29	21,789	$0.00	21,789	$15.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
75,731		2022-03-02	No	4	M	Direct

Footnotes

The weighted average sale price for these transactions was $57.78 per share, with a range of $57.125 to $58.98. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
60,196 shares vested on 03/02/2014; 30,098 shares vested on 03/02/2015; and 30,099 shares vested on 03/02/2016.